Skip to Main Content

Key Action Statement Profile: KAS 5A

Aggregate evidence quality Grade B 
Benefits No adverse effects from antibiotic. Reduces potential for development of bacterial resistance. Reduced costs. 
Risks, harms, cost Small increase in episodes of AOM. 
Benefit-harm assessment Preponderance of benefit. 
Value judgments Potential harm outweighs the potential benefit. 
Intentional vagueness None. 
Role of patient preferences Limited. 
Exclusions Young children whose only alternative would be tympanostomy tubes. 
Strength Recommendation 
Aggregate evidence quality Grade B 
Benefits No adverse effects from antibiotic. Reduces potential for development of bacterial resistance. Reduced costs. 
Risks, harms, cost Small increase in episodes of AOM. 
Benefit-harm assessment Preponderance of benefit. 
Value judgments Potential harm outweighs the potential benefit. 
Intentional vagueness None. 
Role of patient preferences Limited. 
Exclusions Young children whose only alternative would be tympanostomy tubes. 
Strength Recommendation 
Close Modal

or Create an Account

Close Modal
Close Modal